• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Updated assessment of the health risks posed by longer-term consumption of foods contaminated with fipronil

Bioengineer by Bioengineer
August 24, 2017
in Biology
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An average daily intake level was determined for this updated estimation. As the estimation of the risk to consumers was made on the basis of the available data with a number of very conservative assumptions, the expected actual exposure of consumers should lie well below the exposures estimated here.

Based on German and European consumption data (NVS II Model and EFSA PRIMo (Ver.2)), n the ADI value (0.0002 mg/kg body weight per day) is not exceeded for any of the observed consumer groups through the consumption of chicken eggs and chicken meat containing fipronil, including processed foods made from them. With regard to the current fipronil findings, utilisation rates of the ADI of 39% and 12% were estimated for children and adults, respectively, from the consumption data for the German population. ADI utilisation rates of up to 40% were established for the various European consumer groups.

ADI stands for Acceptable Daily Intake and indicates the quantity of a substance which consumers can ingest every day of their lives without any recognisable health risk.

As the updated estimation of the risk to consumers posed by the consumption of chicken eggs and chicken meat containing fipronil, including processed foods made from them, showed no exceedance of the acceptable daily intake levels over an entire lifetime, a health hazard is unlikely.

###

Media Contact

Suzan Fiack
[email protected]
49-301-841-24300
@bfren

http://www.bfr.bund.de/en/home.html

Share12Tweet8Share2ShareShareShare2

Related Posts

Study Challenges Rising Global Trade in Critically Endangered Sand Tiger Sharks

Study Challenges Rising Global Trade in Critically Endangered Sand Tiger Sharks

July 10, 2026
Drosophila as a Key Genetic Model for Studying Extracellular Vesicles

Drosophila as a Key Genetic Model for Studying Extracellular Vesicles

July 10, 2026

BU receives $4.6M grant to advance lung science research training

July 10, 2026

Unmedicated Depressed Women Show Reduced Heat Tolerance Compared to SSRI Users

July 10, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Delirium Rates in German Nursing Homes Revealed in New Study

Unraveling How General Anesthesia Works at the Molecular Level

First Clinical Trial of Stem Cell Therapy for Huntington’s Disease Announced

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 84 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.